Semetra

Product Overview

Semetra is a semaglutide injection (1.34 mg/ml) administered once weekly for adults with type 2 diabetes, either as monotherapy or alongside other treatments.
It offers flexible dosing options (0.25 mg, 0.5 mg, 1 mg) via 1.5 ml or 3 ml prefilled pens.
Semetra is highly effective in lowering HbA1c with minimal risk of hypoglycemia.
Manufactured by Petra Pharma in a GMP-certified facility, it ensures high-quality, bioequivalent medication.
Should be used in combination with a healthy diet and regular exercise.

Indications

Semetra (semaglutide) is prescribed for adults (≥18 years) with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise alone. It can be used:

As monotherapy when metformin is not suitable (intolerance or contraindication)
In combination with other diabetes treatments, including oral agents or insulin
It helps lower blood glucose and may also reduce cardiovascular risk.
Use should always be alongside a healthy diet and regular physical activity.

Key Features

Once-weekly dosing for convenient and consistent diabetes management.

• Flexible dosing options with two prefilled pen sizes (1.5 ml and 3 ml), both containing 1.34 mg/ml semaglutide.
• Broad dosing range to support individualized therapy: 0.25 mg, 0.5 mg, and 1 mg.
• Favorable safety profile with minimal risk of hypoglycemia when used as indicated.
• Powerful HbA1c reduction, supporting effective and sustained glycemic control.
• Manufactured in a GMP-certified facility by Petra Pharma in accordance with international quality standards.
• Bioequivalent formulation, ensuring reliable efficacy and quality comparable to reference products.

Strength and Content

Concentration: 1.34 mg semaglutide per ml

0.25 mg / 0.5 mg pen (1.5 ml):
Contains 1.5 ml solution
Delivers 4 doses of 0.25 mg and 2 doses of 0.5 mg
Pack includes 1 prefilled pen + 6 disposable hypodermic needles (32G, 4 mm)

1 mg pen (3 ml):
Contains 3 ml solution (total 4.02 mg semaglutide)
Each dose delivers 1 mg in 0.74 ml
Pack includes 1 prefilled pen + 4 disposable hypodermic needles (32G, 4 mm)

Manufacturer

Marketing Authorization Holder
Petra Pharmaceutical Industries
Al-Qastal Industrial City, Al-Mushatta, Amman, Jordan

Manufacturer
Novocol Pharmaceutical of Canada, Inc.
25 Wolseley Court, Cambridge, Ontario N1R-6X3, Canada